Skip to content

Mesoprostol and Dilapen in the preparation of the cervix for abortion

Comparison of the effect of Misoprostol and Diplen with Misoprostol in cervical priming in the first and second trimesters

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200603047648N1
Enrollment
196
Registered
2020-07-13
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical abortion in first and second trimester. (Induced) termination of pregnancy with unspecified complications

Interventions

Intervention 1: Control group: Control group: In the control group, to prepare the cervix, 400 micrograms of misoprostol will be placed vaginally by a gynecologist 4 hours before surgery. Mesoprostol

Sponsors

Karaj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age over 18 years for mothers Less or equal pregnancy age 24 weeks based on (LMP) and ultrasound of the first 3 months of pregnancy Patient satisfaction to participate in the study Legal permission for abortion is from the relevant authorities

Exclusion criteria

Exclusion criteria: Patients under 18 years of age Contraindications to the use of misoprostol (drug allergy, active asthma, heart disease, renal failure or glaucoma) Active genital infection Structural disorders of the uterus and bladder Cervical cancer History of cervical surgery

Design outcomes

Primary

MeasureTime frame
Cervical dilatation rate. Timepoint: Before surgery and after general anesthesia. Method of measurement: Examination by a specialist.;Feeling sick. Timepoint: Before surgery and after general anesthesia. Method of measurement: Examination by a specialist doctor based on a five-digit criterion (without discomfort, with discomfort, relatively uncomfortable, very uncomfortable, unbearable).;Servicing preparation time. Timepoint: After receiving the drug until the start of surgery. Method of measurement: Examination by a specialist.

Secondary

MeasureTime frame
Side effects( include vaginal pain, pressure on the bladder, diarrhea and vaginal bleeding, and incomplete miscarriage.). Timepoint: Before general anesthesia, after the procedure and the patient regained consciousness. Method of measurement: Examination by a specialist doctor, ultrasound (if you have symptoms in favor of incomplete abortion once before discharge).;Cervical consistency. Timepoint: Before surgery and after general anesthesia. Method of measurement: Examination by a specialist doctor based on three-digit criteria (according to the surgeon, soft, medium, hard).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactBita Badehnoosh

Karaj University of Medical Sciences

badehnoosh@abzums.ac.ir+98 26 4158 6658

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026